Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pediatrics, Perinatology, and Child Health
Reference35 articles.
1. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–99.
2. Phuong LK, Curtis N, Gowdie P, et al. Treatment options for resistant Kawasaki disease. Pediatr Drugs. 2018;20:59–80.
3. Dusser P, Koné-Paut I. IL-1 Inhibition may have an important role in treating refractory Kawasaki disease. Front Pharmacol. 2017;8:163.
4. Sims JE, Smith DE. Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type II and interleukin-1 receptor accessory protein. Eur Cytokine Netw. 2003;14:77–81.
5. Ramírez J, Canete JD. Anakinra for the treatment of rheumatoid arthritis: a safety evaluation. Expert Opin Drug Saf. 2018;17:727–732.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献